Synthesis of a 10 000 member 1,5-benzodiazepine-2-one library by the directed sorting method

Journal of Combinatorial Chemistry

Volumn 2, Issue 5, 2000, Pages 513-521

  Herpin, Timothy F ^a,b   Van Kirk, Katy G ^a   Salvino, Joseph M ^a   Yu, Sheng Tang ^a   Labaudinière, Richard F ^a  

^a SANOFI   (France)

^b BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; DYNORPHIN; LIGAND;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG DESIGN; METHODOLOGY; MOLECULAR GENETICS; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

AMINES; AMINO ACID SEQUENCE; ANTI-ANXIETY AGENTS; BENZODIAZEPINONES; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; DYNORPHINS; LIGANDS; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034263910     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc000025u     Document Type: Article

References (26)

1. Evans, B. E.; Rittle, K. E.; Bock, M. G.; DiPardo, R. M.; Freidinger, R. M.; Whitter, W. L.; Lundell, G. F.; Veber, D. F.; Anderson, P. S. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J. Med. Chem. 1988, 31, 2235-46.
2. (a) Roemer, D.; Buescher, H. H.; Hill, R. C.; Maurer, R.; Petcher, T. J.; Zeugner, H.; Benson, W.; Finner, E.; Milkowski, W.; Thies, P. W. An opioid benzodiazepine. Nature 1982, 298, 759-60.
3. (b) Zhang, S.; Tong, Y.; Tian, M. D.; Robert, N.; Cortesburgos, L.; Mansson, E.; Simonin, F.; Kieffer, B.; Yu, L. Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family. J. Pharmacol. Exp. Ther. 1998, 286, 136-141.
4. Alho, H.; Costa, E.; Ferrero, P.; Fujimoto, M.; Cosenza-Murphy, D.; Guidotti, A. Diazepam-binding inhibitor: a neuropeptide located in selected neuronal populations of rat brain. Science 1985, 229, 179-82.
5. For recent reviews, see: (a) Dolle, R. E. Comprehensive survey of chemical libraries yielding enzyme inhibitors, receptor agonists and antagonists, and other biologically active agents: 1992 through 1997. Mol. Diversity 1998, 3, 199-233.
6. (b) Dolle, R. E.; Nelson, K. H. Comprehensive survey of combinatorial library synthesis: 1998. J. Comb. Chem. 1999, 1, 235-282.
7. (c) Gordeev, M. F.; Patel, D. P. Heterocyclic Combinatorial Chemistry: Azine and Diazepine Pharmacophores. In Combinatorial Chemistry and Molecular Diversity in Drug Discovery; Gordon, E. M, Kerwin, J. F., Eds.; John Wiley and Sons: New York, 1998.
8. (d) Balkenhohl, F.; von dem Bussche-Huennefeld, C.; Lansky, A.; Zechel, C. Combinatorial synthesis of small organic molecules. Angew. Chem., Int. Ed. Engl. 1996, 35, 2288-2337.
9. (e) Gordon, E. M.; Barrett, R. W.; Dower, W. J.; Fodor, S. P.; Gallop, M. A. Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions. J. Med. Chem. 1994, 37, 1385-401.
10. (a) Plunkett, M. J.; Ellman, J. A. Solid-Phase Synthesis of Structurally Diverse 1,4-Benzodiazepine Derivatives Using the Stille Coupling Reaction. J. Am. Chem. Soc. 1995, 117, 3306-7.
11. (b) Bunin, B. A.; Ellman, J. A. A general and expedient method for the solid-phase synthesis of 1,4-benzodiazepine derivatives. J. Am. Chem. Soc. 1992, 114, 10997-8.
12. (a) Boojamra, C. G.; Burow, K. M.; Thompson, L. A.; Ellman, J. A. Solid-Phase Synthesis of 1,4-Benzodiazepine-2,5-diones. Library Preparation and Demonstration of Synthesis Generality. J. Org. Chem. 1997, 62, 1240-1256.
13. (b) Hulme, C.; Peng. J.; Morton, G.; Salvino, J. M.; Herpin, T.; Labaudiniere, R. Novel safety-catch linker and its ' application with a Ugi/De-BOC/cyclization (UDC) strategy to access carboxylic acids, 1,4-benzodiazepines, diketopiperazines, ketopiperazines and dihydroquinoxalinones. Tetrahedron Lett. 1998, 39, 7227-7230.
14. (c) Mayer, J. P.; Zhang. J.; Bjergarde, K.; Lenz, D. M.; Gaudino, J. J. Solid-phase synthesis of 1,4-benzodiazepine-2,5-diones. Tetrahedron Lett. 1996, 37, 8081-8084.
15. (d) Goff, D. A.; Zuckermann, R. N. Solid-phase synthesis of defined 1,4-benzodiazepine-2,5-dione mixtures. J. Org. Chem. 1995, 60, 5744-5.
16. (e) Boojamra, C. G.; Burow, K. M.; Ellman, J. A. An expedient and high-yielding method for the solid-phase synthesis of diverse 1,4-benzodiazepine-2,5-diones. J. Org. Chem. 1995, 60, 5742-3.
17. (a) Lee, J.; Gauthier, D.; Rivero, R. A. Solid-Phase Synthesis of 3,4,5-Substituted 1,5-Benzodiazepin-2-ones. J. Org. Chem. 1999, 64, 3060-3065.
18. (b) Schwarz, M.; Tumelty, D.; Gallop, M. A. Solid-phase synthesis of 1,5-benzodiazepin-2-ones. Tetrahedron Lett. 1998, 39, 8397-8400.
19. (a) Tranquillini, M. E.; Cassara, P. G.: Corsi, M.; Curotto, G.; Donati, D.; Finizia, G.; Pentassuglia, G.; Polinelli, S.; Tarzia, G.; Ursini, A.; Van Amsterdam, F. T. M. Novel 1,5-benzodiazepines as CCK-B ligands. Effect of aryl-carbamic substituents at the C-3 position together with halogen substitution on the benzo-fused ring. Arch. Pharm. (Weinheim, Ger.) 1997, 330, 353-357.
20. (b) Trist, D.; Pentassuglia, G.; Tranquillini, M. E.; Ursini, A. Preparation of 1H-1,5-benzodiazepinecarbamates and their use as gastrins and cholecystokinin antagonists. PCT Int. Appl. WO 9314075.
21. (a) Batchelor, M. J.; Bebbington, D.; Bemis, G. W.; Fridman, W. H.; Gillespie, R. J.; Golec, J. M. C.; Gu, Y.; Lauffer, D. J.: Livingston, D. J.; Matharu, S. S.; Mullican, M. D.; Murcko, M. A.; Murdoch, R.; Nyce, P. L.; Robidoux, A. L. C. Inhibitors of interleukin-1β converting enzyme. PCT Int. Appl. WO 9722619 A2 19970626, 1997.
22. (b) Bemis, G. W.; Golec, J. M. C.; Lauffer, D. J.; Mullican, M. D.; Murcko, M. A.; Livingston, D. J. Preparation of peptide analogues as inhibitors of interleukin-1 beta converting enzyme (ICE). PCT Int. Appl. WO 9535308.
23. (a) Claremon, D. A.; Freidinger, R. M.; Liverton, N.; Selnick, H. G.; Smith, G. R. Preparation of novel N-(2-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)amides for the treatment of arrhythmia PCT Int. Appl. WO 9640656.
24. (b) Selnick, H. G.; Liverton, N. J. Baldwin, J. J.; Butcher, J. W.; Claremon, D. A.; Elliott, J. M. Freidinger, R. M.; King, S. A.; Libby, B. E.; McIntyre, C. J.; Pribush D. A.; Remy, D. C.; Smith, G. R.; Tebben, A. J.; Jurkiewicz, N. K. Lynch, J. J.; Salata, J. J.; Sanguinetti, M. C.; Siegl, P. K. S.; Slaughter, D. E.; Vyas, K. Class III Antiarrhythmic Activity in Vivo by Selective Blockade of the Slowly Activating Cardiac Delayed Rectifier Potassium Current IKs by (R)-2-(2,4-Trifluoromethyl)-N-[2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-2,3- dihydro-1H-benzo[e][1,4]diazepin-3-yl]acetamide J. Med. Chem. 1997, 40, 3865-3868.
25. Jensen, K. J.; Alsina, J.; Songster, M. F.; Vagner, J.; Albericio, F.; Barany, G. Backbone Amide Linker (BAL) Strategy for Solid-Phase Synthesis of C-Terminal-Modified and Cyclic Peptides J. Am. Chem. Soc. 1998, 120, 5441-5452.
26. Daylight Chemical Information Systems, Inc., 27401 Los Altos, Suite 370, Mission Viejo, CA 92691.